SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Intensive Care Medicine
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
0885066608327095v1
24/1/63    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Ruiz-Alvarez, M.J.
Right arrow Articles by Arribas, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ruiz-Alvarez, M.J.
Right arrow Articles by Arribas, I.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Diagnostic Efficacy and Prognostic Value of Serum Procalcitonin Concentration in Patients With Suspected Sepsis

M.J. Ruiz-Alvarez, PhD

Laboratorio de Analisis Clínicos, Intensivos Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain, mjruizal{at}yahoo.es

S. García-Valdecasas, PhD

Laboratorio de Analisis Clínicos, Intensivos Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain

R. De Pablo, MD, PhD

Unidad de Cuidados, Intensivos Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain

M. Sanchez García, MD, PhD

Unidad de Cuidados Intensivos Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain

C. Coca, MD, PhD

Laboratorio de Analisis Clínicos, Intensivos Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain

T.W. Groeneveld, PhD

Department of Nephrology, Leiden University Medical Center, Leiden, The Netherlands

A. Roos, PhD

Department of Nephrology, Leiden University Medical Center, Leiden, The Netherlands

M.R. Daha, PhD

Department of Nephrology, Leiden University Medical Center, Leiden, The Netherlands

I. Arribas, MD, PhD

Laboratorio de Analisis Clínicos, Intensivos Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain

Background: Procalcitonin is released in response to bacterial infection and it is not released in Inflammatory and viral diseases.

Objective: To show the diagnostic efficacy and prognostic value of procalcitonin for sepsis.

Methods: A consecutive series of 103 patients with suspected sepsis were admitted to the intensive care unit over a 2-year period. During the first 24 hours of the admission procalcitonin, C-reactive protein, and complement proteins were determined. The diagnostic efficacy was tested with predictive values, likelihood ratios, receiver operating characteristic curves, and multiple logistic regression. The association of procalcitonin with mortality was assessed by the Multivariate Cox proportional hazards model.

Results: Procalcitonin had a better positive likelihood ratio than C-reactive protein —2.2 (95% confidence interval: 1.3-3.7) versus 1.1 (95% confidence interval: 0.9-1.2). Sequential Organ Failure Assessment yielded the highest discriminative value, with an area under the curve of 0.82 (95% confidence interval: 0.73-0.92), followed by procalcitonin (0.81; 95% confidence interval: 0.72-0.89). Multivariate regression analysis showed procalcitonin (adjusted odds ratio: 3.8; 95% confidence interval: 1.2-11.8) and Sequential Organ Failure Assessment score (adjusted odds ratio: 5.3; 95% confidence interval: 1.4-19.9) as the only variables independently associated with infection. Multivariate Cox regression analysis revealed that procalcitonin was not independently associated with mortality.

Conclusions: The diagnostic accuracy of procalcitonin was higher than C-reactive protein and complement proteins. Procalcitonin in combination with Sequential Organ Failure Assessment was useful to diagnose infection. C-reactive protein, Sequential Organ Failure Assessment score, age, and gender showed to be helpful to improve the prediction of mortality risk, but not procalcitonin.

Key Words: procalcitonin • C-reactive protein • complement system • diagnosis sepsis • mortality • prognosis

This version was published on January 1, 2009

Journal of Intensive Care Medicine, Vol. 24, No. 1, 63-71 (2009)
DOI: 10.1177/0885066608327095


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement